Bri-Chem (BRY) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
22 Oct, 2026Executive summary
Q3 2024 sales fell 18% YoY to $22.0 million, mainly due to lower US drilling activity; operating earnings and Adjusted EBITDA also declined.
Nine-month sales were $62.5 million, down 21% YoY; the period recorded a net loss of $2.3 million versus net earnings of $442 thousand in 9M 2023.
Financial highlights
Q3 sales were $22.0 million versus $26.8 million; gross margin dollars decreased $1.1 million YoY, primarily due to lower US divisional sales.
Q3 operating earnings were $234 thousand, down 80% YoY; Adjusted EBITDA was $587 thousand, down 44%, with margin at 3% versus 4%.
Q3 Adjusted net loss was $549 thousand versus $293 thousand; net loss improved to $269 thousand from $376 thousand.
9M revenue was $62.5 million, down 21%; operating earnings were $710 thousand versus $3.7 million, while Adjusted EBITDA was $851 thousand versus $4.6 million.
Outlook and guidance
For FY2025, outlook remains optimistic given recent US election results and the prospect of more favorable oil and gas drilling policies.
Sustained commodity price stability could strengthen customers’ balance sheets and support increased drilling activity; strategies will be adjusted as market conditions evolve.
Latest events from Bri-Chem
- Sales grew 16%, but higher costs and lower margins cut adjusted EBITDA 34%.BRY
Q1 2023 - Q4 adjusted EBITDA rose 35%, while FY operating earnings fell 40%.BRY
Q4 2023 - Adjusted EBITDA rose, but lower U.S. drilling sales weighed on Q2 revenue.BRY
Q2 2023 - Lower U.S. rig activity and margin pressure cut Q3 earnings; a modest 2024 recovery is possible.BRY
Q3 2023 - Lower US drilling drove a 24% sales decline and Q2 net loss.BRY
Q2 2024 - Lower drilling activity drove a 21% sales decline and a $443K Adjusted EBITDA loss.BRY
Q1 2024 - Lower sales and a $1.1M bad-debt write-off drove FY adjusted EBITDA negative.BRY
Q4 2024 - Lower US drilling cut sales 7%, while adjusted EBITDA returned to positive territory.BRY
Q1 2025 - Q2 earnings improved as sales rose, but Canadian demand remains soft.BRY
Q2 2025